| 000 | 01192 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516143911.0 | ||
| 264 | 0 | _c20140218 | |
| 008 | 201402s 0 0 eng d | ||
| 022 | _a1996-3181 | ||
| 024 | 7 |
_a10.2174/1871527311312040005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCzysz, Andrew H | |
| 245 | 0 | 0 |
_aG-protein signaling, lipid rafts and the possible sites of action for the antidepressant effects of n-3 polyunsaturated fatty acids. _h[electronic resource] |
| 260 |
_bCNS & neurological disorders drug targets _cJun 2013 |
||
| 300 |
_a466-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntidepressive Agents _xpharmacology |
| 650 | 0 | 4 |
_aCaveolae _xdrug effects |
| 650 | 0 | 4 |
_aFatty Acids, Omega-3 _xpharmacology |
| 650 | 0 | 4 |
_aGTP-Binding Proteins _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMembrane Microdomains _xdrug effects |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aRasenick, Mark M | |
| 773 | 0 |
_tCNS & neurological disorders drug targets _gvol. 12 _gno. 4 _gp. 466-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1871527311312040005 _zAvailable from publisher's website |
| 999 |
_c22658040 _d22658040 |
||